FDA capital planning investment control (cpic)
Ended Awarded Last action
- Contract number
- 75F40122F80271
- Awardee
-
Metaphase Consulting LLC UEI ZH8ACM4ZWDL7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,161,412
Award facts
- Contract value 100% obligated
- $2,161,411.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$92,651 | |
| Other Administrative Action | -$629,228 | |
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Exercise an Option | $845,508 | |
| Exercise an Option | $828,425 | |
| Other Administrative Action | -$88 | |
| Exercise an Option | $811,755 | |
| Other Administrative Action | $0 | |
| Original award | $397,690 |
About this award
The Food and Drug Administration awarded a delivery order contract modification to Metaphase Consulting LLC, a Hispanic American-owned, SBA-certified 8(a) small business based in Reston, Virginia, to de-obligate funds and close out the contract. This delivery order, issued under the 8(a) STARS III Government-Wide Acquisition Contract, carries a ceiling value of $2.16 million and operates under labor-hour pricing. The contract, which was originally awarded on August 1, 2022, is scheduled for ultimate completion on September 5, 2025, with performance taking place in Reston, Virginia. The competitive 8(a) set-aside designation reflects the procurement's commitment to supporting small disadvantaged business enterprises in federal contracting.
Metaphase Consulting specializes in comprehensive IT and management consulting services to federal agencies, with particular expertise in technology modernization, process improvement, organizational transformation, and strategic consulting. The firm maintains an extensive portfolio of federal contracts, including positions on multiple government-wide acquisition vehicles such as OASIS+, STARS III, and eFAST, along with substantial agency-specific blanket purchase agreements and indefinite delivery/indefinite quantity contracts with departments including Treasury, State, Commerce, and the Federal Emergency Management Agency. The closure of this FDA delivery order reflects the natural contract lifecycle management and fund management practices typical across federal civilian agencies.
Quick answers
Who was awarded contract 75F40122F80271?
75F40122F80271 was awarded to Metaphase Consulting LLC by Food and Drug Administration (Department of Health and Human Services) on August 1, 2022.
How much is contract 75F40122F80271 worth?
The government has obligated $2,161,412 on 75F40122F80271.
Is contract 75F40122F80271 an order under another contract?
Yes. 75F40122F80271 is a delivery order under 47QTCB22D0095, a government wide acquisition contract (GWAC), on 8(a) STARS III (STARS III).
Was contract 75F40122F80271 competed?
The extent of competition for 75F40122F80271 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award